Literature DB >> 16557657

Influenza vaccines.

Mark J Belsey1, Brigitte de Lima, Alex K Pavlou, John W Savopoulos.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16557657     DOI： 10.1038/nrd1988

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  8 in total

Review 1.  Pricing of new vaccines.

Authors:  Bruce Y Lee; Sarah M McGlone
Journal:  Hum Vaccin       Date:  2010-08

2.  Cell culture-derived flu vaccine: Present and future.

Authors:  Alberto Pérez Rubio; Jose María Eiros
Journal:  Hum Vaccin Immunother       Date:  2018-06-28       Impact factor: 3.452

Review 3.  Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles.

Authors:  Bruce Y Lee; Donald S Burke
Journal:  Vaccine       Date:  2009-09-25       Impact factor: 3.641

4.  MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells.

Authors:  Ding Yuan Oh; Ian G Barr; Jenny A Mosse; Karen L Laurie
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

5.  Production of avian influenza virus vaccine using primary cell cultures generated from host organs.

Authors:  Mustafeez Mujtaba Babar; Muhammad Suleman Riaz; Najam-us-Sahar Sadaf Zaidi; Farhan Afzal; Muhammad Sabir Farooq
Journal:  J Ind Microbiol Biotechnol       Date:  2013-03-21       Impact factor: 3.346

6.  Specific temperature-induced perturbations of secondary mRNA structures are associated with the cold-adapted temperature-sensitive phenotype of influenza A virus.

Authors:  Andrey Chursov; Sebastian J Kopetzky; Ignaty Leshchiner; Ivan Kondofersky; Fabian J Theis; Dmitrij Frishman; Alexander Shneider
Journal:  RNA Biol       Date:  2012-09-20       Impact factor: 4.652

7.  Low seroprevalent species D adenovirus vectors as influenza vaccines.

Authors:  Eric A Weaver; Michael A Barry
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

8.  Bacterially produced recombinant influenza vaccines based on virus-like particles.

Authors:  Andrea Jegerlehner; Franziska Zabel; Alice Langer; Klaus Dietmeier; Gary T Jennings; Philippe Saudan; Martin F Bachmann
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.